Skip to Content
Learn about Adcetris a treatment of Hodgkin Lymphoma

Carboplatin Pregnancy and Breastfeeding Warnings

Carboplatin is also known as: Carboplatin Novaplus, Paraplatin

Medically reviewed on Sep 24, 2018

Carboplatin Pregnancy Warnings

Carboplatin has been assigned to pregnancy category D by the FDA. Animal studies have revealed evidence of embryotoxicity and teratogenicity. There are no controlled data in human pregnancy. Carboplatin is only recommended for use during pregnancy when there are no alternatives and benefits outweigh risks.

See references

Carboplatin Breastfeeding Warnings

There are no data on the excretion of carboplatin into human milk. Because many drugs are excreted into human milk and because of the potential for serious adverse reactions due to carboplatin in nursing infants, a decision should be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.

See references

References for pregnancy information

  1. "Product Information. Paraplatin (carboplatin)." Bristol-Myers Squibb, Princeton, NJ.

References for breastfeeding information

  1. "Product Information. Paraplatin (carboplatin)." Bristol-Myers Squibb, Princeton, NJ.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.